Emicizumab-kxwh Subcutaneous and Insulin glargine and lixisenatide
Determining the interaction of Emicizumab-kxwh Subcutaneous and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Emicizumab-kxwh Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Emicizumab-kxwh Subcutaneous-Insulin glulisine
- Emicizumab-kxwh Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Emicizumab-kxwh Subcutaneous-Insulin Glulisine (Vials)
- Emicizumab-kxwh Subcutaneous-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Emla
- Insulin glargine and lixisenatide-Emla Topical
- Insulin glargine and lixisenatide-Emo-Cort Scalp Solution Topical application
- Insulin glargine and lixisenatide-Emo-Cort Topical application
- Insulin glargine and lixisenatide-Emoquette
- Insulin glargine and lixisenatide-Empagliflozin